Compound may block ability of malaria parasite to survive in blood

07/3/2014 |

Australian researchers have found that the experimental drug compound WEHI-916 can kill the malaria parasite by blocking plasmepsin V, an enzyme that allows the parasite to move from the liver to the blood. The study in the journal PLOS Biology shows that plasmepsin V is necessary for the parasite's survival, researcher Justin Boddey said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT